Fierce Healthcare
AUGUST 31, 2023
The American Telemedicine Association, the College of Healthcare Information Management Executives (CHIME) and Otsuka America Pharmaceutical are among the groups in support of the Centers for Medic | Organizations signed a letter pledging support for a CMS-backed transitional coverage for emergency technologies pathway, which they say could improve (..)
HIT Consultant
AUGUST 21, 2023
These demographic trends are causing shifts within the healthcare sector and resulting in increased expenditure associated with the costs of treatment and prevention in old age. Both a lack of clinical engagement and inadequate resources are two often-cited areas that prevent better integration of otherwise promising digital solutions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
SEPTEMBER 26, 2022
There was tremendous interest in telemedicine before 2020. For instance, digital-first healthcare aggregators had been testing programs for telemedicine but, since 2020, the demand for telehealth services has exploded across the globe. The new normal has thrown up opportunities as well as risks for pharmaceutical companies.
Bill Of Health
NOVEMBER 28, 2022
In 2021, the total revenue of Italian pharmacies dropped by 4% compared to 2015, despite Italy being the fifth largest country in the EU for pharmaceutical expenditures. This contraction in total revenue was mainly influenced by the decline in Italian pharmaceutical expenditures over the last decade: compared to the revenue of 18.8
HIT Consultant
JANUARY 13, 2023
This shortage became a critical issue during the pandemic when people relied heavily on telemedicine and the advice of doctors to carry them through the unprecedented time. Community pharmacies will also be moving into the role of preventative care providers in 2023.
Bill Of Health
MAY 30, 2023
By Katie Gu Mifepristone’s shifting legal terrain may soon raise new privacy considerations regarding telemedicine data collection, security, and disclosure. During the pandemic, changes to mifepristone’s REMS requirements allowed increased prescription access in some states via telemedicine and mail dispensing. Since its original U.S.
Health Populi
MAY 14, 2020
#StayHome, shelter-in-place mandates coupled with patients’ concerns about preventing personal exposure to the coronavirus, kept people home. That decline in face-to-face physician visits was supplanted, in part, by hockey-stick growth for telemedicine visits. Overall in-person visits to doctors fell by over 70%.
Expert insights. Personalized for you.
276 
Let's personalize your content